Handmade quality · Free shipping over $75 · Explore the atelier

NX-13 Catalog No.:M15889-10 coadministration of Tariquidar (XR9576) potentiates

SKU: 87393132306

4.0
USD155.00 USD195.00

Pay in 4 interest-free payments of $38.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

coadministration of Tariquidar (XR9576) potentiates the antitumor activity of Doxorubicin without a significant increase in toxicity

(E)-Ferulic acid methyl ester (Methyl (E)-ferulate) exhibits strong DPPH and ABTS+ radical scavenging activities

and stable small molecule that transcriptionally induces TRAIL in a p53-independent manner and crosses the blood-brain barrier

CAS Number: 632325-71-4

GLUD1/2) inhibitor

NX-13 Catalog No.:M15889-10 coadministration of Tariquidar (XR9576) potentiatesNX 13 is a first in class, orally active and gut restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX 13 results in lower inflammation and responses in inflammatory bowel disease. NX 13 can be used for the research of crohn's disease and ulcerative colitis. Product information CAS Number: 2389235 01 0 Molecular Weight: 399. 44 Formula: C24H21N3O3 Chemical Name: 2 {3, 5 bis[(6 methylpyridin 2

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products